Adefovir dipivoxil: A third-line option in chronic hepatitis B

Prescrire International

Volumn 13, Issue 69, 2004, Pages 4-7

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; CREATININE; LAMIVUDINE; NUCLEOTIDE DERIVATIVE; PLACEBO; PRODRUG; ADENINE; ALPHA INTERFERON; DRUG DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ABDOMINAL PAIN; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CREATININE BLOOD LEVEL; DRUG APPROVAL; DRUG CHOICE; DRUG MARKETING; DRUG TOLERABILITY; EUROPEAN UNION; FATALITY; FATIGUE; HEADACHE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LACTIC ACIDOSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MONITORING; NAUSEA; NEPHROTOXICITY; REVIEW; TERATOGENICITY; VIRUS LOAD; VIRUS REPLICATION; ANTIBIOTIC RESISTANCE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FRANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES; VIROLOGY;

ADENINE; ANTIVIRAL AGENTS; CLINICAL TRIALS; COHORT STUDIES; DRUG APPROVAL; DRUG RESISTANCE, VIRAL; EUROPEAN UNION; FRANCE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LAMIVUDINE; PRODRUGS; RANDOMIZED CONTROLLED TRIALS; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; UNITED STATES;

EID: 1042291944     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Prescrire Editorial Staff "Treatment of chronic hepatitis B" Prescribe Int 2001; 10(51): 17-21.
2. Prescrire Editorial Staff "Lamivudine" Prescrire Int 2001; 10 (51): 18.
3. Cundy KC " Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir" Clin Pharmacokinet 1999; 36 (2): 127-143.
4. Lok AS and McMahon BJ "Chronic hepatitis B" Hepatology 2001; 34 (6): 1225-1241.
5. Brook MG "European guideline for the management of hepatitis B and C virus infections" Int J STD Aids 2001; 12 (suppl. 3): 48-57.
6. Commission de la transparence "Avis de la Commision - Zeffix" 23 January 2002: 5 pages.
7. The European Agency for the Evaluation of Medicinal Products - Committee for Proprietary Medicinal Products - European Public Assessment Report (EPAR) "Hepsera" 24 March 2003: 57 pages.
8. Gilead "FDA advisory committee briefing document. Adefovir dipivoxil for the treatment of chronic hepatitis B" 5 July 2002: 135 pages.
9. Marcellin P et al. "Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B" N Eng J Med 2003; 348 (9): 808-816 + 348 (24): 2468.
10. Hadziyannis SJ et el. "Adefovir dipivoxil for the treatment of hepatitis Be antigen-negative chronic hepatitis B" N Eng J Med 2003; 348 (9): 800-807.
11. Gilead "Does données sur 96 semaines indiquent que l'Hepsera réduit l'atteinte hépatique et améliore les fonctions hépatiques chez plus 70 % des patients..." 10 April 2003: 5 pages.
12. Dusheiko G "Efficacy and safety of adefovir dipivoxil in lamivudine resistant HBV" January 2003; 8 pages.
13. Zoulim F et al. "Adefovir dipivoxil (ADV) for the treatment of patients with chronic hepatitis B (CHB) failing lamivudine (LAM) therapy" Congrès EASL November 2002; abtr.: 1 page.
14. Benhamou Y et al. "Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamiduvine-resistant hepatitis B virus:an open-label pilot study" Lancet 2001; 358: 718-723.
15. Food and Drug Administration - Adefopovir review team "Briefing document for NDA 21-449:adefovir dipivoxil" 10 July 2002: 36 pages.
16. Prescrire Editorial Staff "Antiretroviral drugs: lactic acidosis" Prescrire Int 2002; 11 (60): 113-115.
17. Prescrire Rédaction "Sérologie et histologie de l'hépatite B chronique" Rev Prescrire 2000; 20 (210): 691.